Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis
一项观察者盲法试验比较了局部应用奥洛他定（0.1%）、贝波他汀（1.5%）和阿卡他定（0.25%）治疗轻度至中度过敏性结膜炎的疗效。
期刊:Indian Journal of Ophthalmology
影响因子:1.8
doi:10.4103/ijo.IJO_2112_18
Dudeja, Lakshey; Janakiraman, Anuja; Dudeja, Ishani; Sane, Kaustubh; Babu, Manohar
